Evidence map›Paper›PMID 38915339›Full record

ArticleOpen forum infectious diseases2024

Thibault Kerdiles, Sophie Lejeune, Antoine Portais, Gaelle Bourgeois, Benjamin Lefevre, Alexandre Charmillon, Thibault Sixt, Florian Moretto, Cyril Cornille, Magali Vidal and 14 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. ConcurrentCase reports in infectious diseases · 2026
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Thibault KerdilesAP-HP, Département des Maladies Infectieuses et Tropicales, Hôpital Saint-Louis, Lariboisière, Paris, France.ORCID https://orcid.org/0009-0000-3194-4694
Sophie LejeuneService de maladies infectieuses et tropicales, CHU Grenoble Alpes, Grenoble, France.
Antoine PortaisService de maladies infectieuses et tropicales, CHU Grenoble Alpes, Grenoble, France.
Gaelle BourgeoisService de Maladies Infectieuses, Centre Hospitalier Metropole Savoie, Chambéry, France.
Benjamin LefevreService des Maladies Infectieuses et Tropicales, CHRU-Nancy, Université de Lorraine, Nancy, France.
Alexandre CharmillonService des Maladies Infectieuses et Tropicales, CHRU-Nancy, Université de Lorraine, Nancy, France.
Thibault SixtInfectious Diseases Department, Dijon University Hospital, Dijon, France.ORCID https://orcid.org/0000-0002-2966-6346
Florian MorettoInfectious Diseases Department, Dijon University Hospital, Dijon, France.ORCID https://orcid.org/0000-0003-0159-4026
Cyril CornilleService des maladies infectieuses et tropicales, Hôpital universitaire de Clermont-Ferrand, Clermont-Ferrand, France.ORCID https://orcid.org/0000-0001-5244-0890
Magali VidalService des maladies infectieuses et tropicales, Hôpital universitaire de Clermont-Ferrand, Clermont-Ferrand, France.ORCID https://orcid.org/0000-0002-3977-9846
François CoustillèresService de Médecine Interne-Maladies Infectieuses, CHRU Tours, Tours, France.
Jean-Philippe MartellosioService de médecine interne, maladies infectieuses et tropicales, CHU de Poitiers, Université de Poitiers, Poitiers, France.ORCID https://orcid.org/0000-0003-0886-7699
Marion QuenetService de Médecine Polyvalente, Centre Hospitalier Yves Le Foll, Saint-Brieuc, France.
Martin BelanEquipe Mobile d'Infectiologie, Hôpitaux Universitaires Paris Centre-Cochin Port Royal, Assistance publique Hôpitaux de Paris (AP-HP), Paris, France.
Fanny AndryService de Maladies Infectieuses et Dermatologie, CHU de la Réunion, Saint Pierre, France.ORCID https://orcid.org/0000-0001-6343-5130
Karim JaffalService des Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire Raymond Poincaré, Assistance publique Hôpitaux de Paris (AP-HP), Garches, France.
Angela Pinazo-MeliaService de pneumologie, Hôpitaux civils de Colmar, Colmar, France.
Paul RondeauService de Médecine interne, Hôpital Saint-Camille, Bry-sur-Marne, France.
David Luque PazInfectious Diseases and Intensive Care Unit, Pontchaillou University Hospital, Rennes, France.ORCID https://orcid.org/0000-0002-9197-7305
Stephane JouneauDepartment of Respiratory Medicine, CHU Rennes, Rennes, France.
Raphael BorieService de Pneumologie A Hôpital Bichat, Assistance publique Hôpitaux de Paris (AP-HP), Université Paris Cité, Inserm, PHERE, Université Paris Cité, Paris, France.ORCID https://orcid.org/0000-0002-9906-0024
Delphine MonnierService d'Immunologie, CHU Rennes, Rennes, France.ORCID https://orcid.org/0000-0001-8891-3450
David LebeauxAP-HP, Département des Maladies Infectieuses et Tropicales, Hôpital Saint-Louis, Lariboisière, Paris, France.ORCID https://orcid.org/0000-0002-7164-831X
GM-Noc Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Nocardiosis, a bacterial opportunistic infection caused by Methods: We performed a prospective, multicenter, nationwide study in France and included patients with a Results: Twenty patients (18 [90%] male) were included, with a median age of 69 (interquartile range, 44-75) years. The organs most frequently involved were the brain (14/20 [70%]) and the lung (12/20 [60%]). Half of the infections were disseminated (10/20 [50%]). Conclusions: Nocardiosis with anti-GM-CSF autoantibodies is associated with a low mortality rate despite a high incidence of brain involvement. Although the occurrence of aPAP was infrequent during the 1-year follow-up period, long-term clinical data are needed to fully understand the potential relationship between nocardiosis, anti-GM-CSF autoantibodies, and aPAP.

Indexed as

anti-GM-CSF autoantibodiesautoimmune pulmonary alveolar proteinosiscentral nervous system infectionNocardianocardiosis

Identifiers

PMID38915339
PMCPMC11194753

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.